QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 8, 2007, Pages 3096-3103

  Camargo, Alejandra B ^a   Marchevsky, Eduardo ^b   Luco, Juan M ^b  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

Garlic; Multivariate quantitative structure activity relationships (QSARs); Organosulfur compounds (OSCs); Soybean 15 lipoxygenase (15 sLO)

Indexed keywords

ALLYL COMPOUND; ALLYL SULFIDE; ARACHIDONATE 15 LIPOXYGENASE; ESSENTIAL OIL; LIPOXYGENASE INHIBITOR; SULFIDE; SULFUR DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; SOYBEAN;

ALLYL COMPOUNDS; ARACHIDONATE 15-LIPOXYGENASE; LIPOXYGENASE INHIBITORS; OILS, VOLATILE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS; SOYBEANS; SULFIDES; SULFUR COMPOUNDS;

ALLIUM SATIVUM; GLYCINE MAX;

EID: 34247582192     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf063020e     Document Type: Article

References (25)

1. Solomon, E. I.; Zhou, J.; Neese, F.; Pavel, E. G. New insights from spectroscopy into the structure/function relationships of lipoxygenases. Chem. Biol. 1997, 4, 795-808.
2. Brash, A. R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 1999, 274, 23679-23682.
3. Roberts, L. J., II. Introduction: lipids as regulators of cell function. Cell. Mol. Life Sci. 2002, 59, 727-728.
4. Samuelsson, B.; Dahlen, S. E.; Lindgren, J. A.; Rouzer, C. A.; Serhan, C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987, 237, 1171-1176.
5. Dailey, L. A.; Imming, P. 12-Lipoxygenase: classification, possible therapeutic benefits from inhibition, and inhibitors. Curr. Med. Chem. 1999, 6, 389-398.
6. Ding, X. Z.; Tong, W. G.; Adrian, T. E. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology 2001, 1, 291-299.
7. Cornicelli, J. A.; Trivedi, B. K. 15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease. Curr. Pharm. Des. 1999, 5, 11-20.
8. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-924.
9. Minor, W.; Steczko, J.; Stec, B.; Otwinowski, Z.; Bolin, J. T.; Walter, R.; Axelrod, B. Crystal structure of soybean lipoxygenase L-1 at 1.4 Å resolution. Biochemistry 1996, 35, 10687-10701.
10. Kuhn, H.; Saam, J.; Eibach, S.; Holzhutter, H. G.; Ivanov, I.; Walther, M. Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure. Biochem. Biophys. Res. Commun. 2005, 338, 93-101.
11. Pontiki, E.; Hadjipavlou-Litina, D. Lipoxygenases (LOs): a heterogenous family of lipid peroxidizing enzymes implicated in cell differentiation, inflammation, asthma, carcinogenesis, atherogengsis-an interesting target for the development of promising drugs. Curr. Enzyme Inhib. 2005, 1, 309-327.
12. Rabinowitch, H. D., Currah, L., Eds. Health and alliums. In Allium Crop Science: Recent Advances; CAB International: Wallingford, U.K., 2002; 515 pp.
13. Camargo, A. B.; Masuelli, R. W.; Burba, J. L. Characterization of Argentine garlic cultivars for their allicin content. Acta Hortic. 2005, 688, 309-312.
14. Tapiero, H.; Townsend, D.; Tew, K. Organosulfur compounds from alliaceae in the prevention of human pathologies. Biomed. Pharmacother. 2004, 58, 183-193.
15. Sing, U.; Prithiviraj, B.; Sarma, B. K.; Sing, M.; Ray, A. B. Role of garlic (Allium sativum L.) in human and plant diseases. Indian J. Exp. Biol. Indian 2001, 39, 310-322.
16. Block, E.; Iyer, R.; Grisoni, S.; Saha, C.; Belman, S.; Lossing, F. P. Lipoxygenase inhibitors from the essential oil of garlic. Markovnikov addition of the allyldithio radical to olefins. J. Am. Chem. Soc. 1988, 110, 7813-7827.
17. Wold, S. PLS for multivariate linear modeling. In Chemometric Methods in Molecular Design; Van de Waterbeemd, H., Ed.; Wiley-VCH: Weinheim, Germany, 1995; Vol. 2, pp 195-218.
18. Luco, J. M. Prediction of brain-blood distribution of a large set of drugs from stucturally-derived descriptors using partial least squares (PLS) modeling. J. Chem. Inf. Comput. Sci. 1999, 39, 396-404.
19. Silva, M. F.; Chipre, L. F.; Raba, J.; Luco, J. M. Amino acids characterization by reversed-phase liquid chromatography. Partial least-squares modeling of their transport properties. Chromatographia 2001, 53, 392-400.
20. Luco, J. M.; Salinas, A. P.; Torriero, A. A. J.; Vazquez, R. N.; Raba, J.; Marchevsky, E. J. Immobilized artificial membrane chromatography: quantitative structure-retention relationships of structurally diverse drugs. J. Chem. Inf. Comput. Sci. 2003, 43, 2129-2136.
21. Luco, J. M.; Marchevsky, E.; QSAR Studies on blood-brain barrier permeation. Curr. Comput.-Aided Drug Design 2006, 2, 31-55.
22. Todeschini, R.; Consonni, V. In Handbook of Molecular Descriptors; Mannhold, R., Kubinyi, H., Timmerman, H., Eds.; Wiley-VCH: Weinheim, Germany, 2000; Vol. 11, pp 1-667.
23. Ruddat, V. C.; Mogul, R.; Chomy, I.; Chen, C.; Perrin, N.; Whitman, S.; Kenyon, V.; Jacobson, M. P.; Bernasconi, C. F.;Holman, T. R. Tryptophan 500 and arginine 707 define product and substrate active site binding in soybean lipoxygenase-1. Biochemistry 2004, 43, 13063-13071.
24. Pullman, B.; Pullman, A. Electron-donor and acceptor properties of biologically important purines, pyrimidines, pteridines, flavins, and aromatic amino acids. Proc. Natl. Acad. Sci. U.S.A. 1958, 44, 1197-1202.
25. Eriksson, L.; Johansson, E.; Muller, M.; Wold, S. Cluster-based design in environmental QSAR. Quant. Struct.-Act. Relat. 1997, 16, 383-390.